Showing results (51-60 of 57) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Journal of Neurology, Neurosurgery, and Psychiatry|June 2, 2023
Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrumSu Yeon Park, Young Nam Kwon, Sunyoung Kim, et al.Journal of Alzheimer'S Disease : JAD|November 20, 2018
Observational Study of Clinical and Functional Progression Based on Initial Brain MRI Characteristics in Patients with Alzheimer's DiseaseHojin Choi, YoungSoon Yang, Hyun Jeong Han, et al.JAMA Neurology|September 3, 2024
Time to Treat First Acute Attack of Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseYoung Nam Kwon, Boram Kim, Jun-Soon Kim, et al.Journal of Neurology|November 17, 2022
Clinical pitfalls and serological diagnostics of MuSK myasthenia gravisYoung Nam Kwon, Mark Woodhall, Jung-Joon Sung, et al.Journal of Clinical Neurology (Seoul, Korea)|March 11, 2025
Evaluating Rituximab Failure Rates in Neuromyelitis Optica Spectrum Disorder: A Nationwide Real-World Study From South KoreaSu-Hyun Kim, Ju-Hong Min, Sung-Min Kim, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|August 12, 2020
Comparison of MOG and AQP4 antibody seroprevalence in Korean adults with inflammatory demyelinating CNS diseasesJae-Won Hyun, Hye Lim Lee, Woo Kyo Jeong, et al.Neurology|March 12, 2026
Prevalence and Relative Proportions of Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease in the Republic of KoreaSu-Hyun Kim, Eun-Jae Lee, Young-Min Lim, et al.Pageof 6